Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus.

Saved in:
Bibliographic Details
Title: Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus.
Authors: Handelsman Y; Metabolic Institute of America, Los Angeles, CA, USA., Cheng AYY; Department of Medicine, University of Toronto, Toronto, Canada., Fadini GP; Department of Medicine, University of Padova, Padua, Italy., Kushner P; University of California Irvine Medical Center, Orange, CA, USA., Bonnet F; Department of Diabetes, University of Rennes, Rennes, France., Fioretto P; Department of Medicine, University of Padova, Padua, Italy., Kadowaki T; Toranomon Hospital, Tokyo, Japan., Kanumilli N; Northenden Group Practice, Wythenshawe, UK., Cos X; IDIAP Jordi Gol, Institut Català de la Salut, CIBERDEM, Barcelona, Spain., Frese T; Institute of General Practice and Family Medicine, Interdisciplinary Center of Health Sciences, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany., Ji L; Department of Internal Medicine, Peking University People's Hospital, Beijing, China., Rossing P; Department of Clinical Medicine, Internal Medicine, Endocrinology, University of Copenhagen, Copenhagen, Denmark. Peter.Rossing@RegionH.dk.
Source: Advances in therapy [Adv Ther] 2026 May 30. Date of Electronic Publication: 2026 May 30.
Publication Type: Journal Article
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1865-8652
DOI:10.1007/s12325-026-03618-z